Navigation Links
New Data for Abbott's TRILIPIX(R) (fenofibric acid) in Combination with Rosuvastatin Calcium Shows Improvement on Key Lipids for Cholesterol Management
Date:3/29/2009

TRILIPIX has now been studied in combination with the most commonly used doses of rosuvastatin calcium (5 mg, 10 mg, 20 mg) in patients with mixed dyslipidemia

ORLANDO, Fla., March 29 /PRNewswire-FirstCall/ -- Data from a new study showed that Abbott's TRILIPIX(R) (fenofibric acid) delayed-release capsules in combination with rosuvastatin calcium met all of the study's primary endpoints. TRILIPIX 135 mg in combination with rosuvastatin calcium 5 mg significantly improved HDL cholesterol and triglycerides compared to rosuvastatin calcium 5 mg alone, and significantly improved LDL cholesterol compared to TRILIPIX 135 mg alone in patients with multiple lipid problems. Results from this new Phase III study were presented today at the American College of Cardiology's 2009 Scientific Sessions in Orlando.

TRILIPIX is a prescription medicine that can be used along with diet to lower triglycerides and LDL (bad) cholesterol, and increase HDL (good) cholesterol. TRILIPIX can also be used along with diet to lower triglycerides and increase HDL cholesterol in people who are at high risk of heart disease and are taking a statin medicine to control their LDL cholesterol. TRILIPIX has not been shown to prevent heart attacks or stroke more than a statin alone.

TRILIPIX is the first and only fibrate to be approved for use in combination with a statin. In certain patients, treatment guidelines recommend the combination of a fibrate with a statin to improve lipid levels.

In the clinical trial, TRILIPIX in combination with rosuvastatin calcium was generally well-tolerated with reported safety similar to rosuvastatin calcium alone and TRILIPIX alone. No unexpected liver, kidney or muscle safety issues were identified in this study. Muscle related problems can occur with TRILIPIX and rosuvastatin calcium alone. The risk of these side effects may be incre
'/>"/>

SOURCE Abbott
Copyright©2009 PR Newswire.
All rights reserved

6

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Oncolytics Biotech(R) Inc. Announces Start of Enrolment in U.S. Phase 2 Combination Clinical Trial for Non-Small Cell Lung Cancer Patients with K-RAS or EGFR-Activated Tumours
2. FDA Approves an Expanded Indication for Peginterferon-Based Combination Therapy for Patients With Chronic Hepatitis C
3. Studies Show Combination Laser Therapy Effective At Clearing Acne, Reducing Oil Production
4. New Study Using Combination of Bioengineered Skin and Stem Cells Shows Promise in Treatment of Non-Healing Wounds
5. Novexels NXL104/ceftazidime Combination Commences Second Phase II Clinical Trial in Hospital Patients With Complicated Intra-Abdominal Infections (cIAIs)
6. Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data on KRX-0401 (Perifosine) in Combination with Bortezomib (+/- Dexamethasone) at the 12th International Multiple Myeloma Meeting
7. Phase 1 Trial of Quadramet in Combination with Velcade Shows Positive Results
8. Pivotal Data Published For First Biomarker Combination Test to Determine Risk of Ovarian Cancer in Women Who Present With Pelvic Mass
9. Access Pharmaceuticals Presents new Combination Data on the Companys Angiolix(R) Therapeutic Monoclonal Antibody
10. AcelRx Pharmaceuticals Reports Positive Results from a Clinical Trial of Sublingual Sufentanil/Triazolam NanoTab(TM) Combination (ARX-03) in Treating Procedural Pain and Anxiety
11. InterMune to Conduct Conference Call and Webcast to Discuss Results of Triple Combination Study of ITMN-191
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2010)... LOUIS , Feb. 8 Cost ... Healthcare Products (Nasdaq: AHPI ) narrowly back into ... ,, Sales for the quarter ended December 31, ... $12.5 million during the same quarter last year ... However, Allied,s costs of sales were reduced even more ...
(Date:2/8/2010)... EAST BRUNSWICK, N.J. , Feb. 8 /PRNewswire-FirstCall/ ... today that the company will release financial results for ... of the market on Thursday, February 25, 2010 ... David Gionco, Group Vice President and Chief Financial Officer, ... 10:00 a.m. Eastern Time on February ...
(Date:2/8/2010)... Feb. 8 Hanger Orthopedic Group, Inc. (NYSE: ... report its results of operations for the year ended ... . ,, The Company plans to issue a press release ... 2009 on Wednesday, February 10, 2010 , after ... to begin at 9:00 a.m., EST , on ...
Breaking Medicine Technology:Allied Healthcare Products Returns to Profitability By Offsetting Depressed Sales with Cost Reductions 2Allied Healthcare Products Returns to Profitability By Offsetting Depressed Sales with Cost Reductions 3Allied Healthcare Products Returns to Profitability By Offsetting Depressed Sales with Cost Reductions 4Allied Healthcare Products Returns to Profitability By Offsetting Depressed Sales with Cost Reductions 5Allied Healthcare Products Returns to Profitability By Offsetting Depressed Sales with Cost Reductions 6Savient Pharmaceuticals To Hold Fourth Quarter And Year-End 2009 Results Conference Call On Friday, February 26, 2010 2Hanger Orthopedic Group, Inc. Announces 2009 Year-End Earnings Release Conference Call 2New type of genetic change identified in inherited cancer 58828 1New type of genetic change identified in inherited cancer 58828 2New type of genetic change identified in inherited cancer 58828 3Study finds 231 new genes associated with head and neck cancer 10252 1Study finds 231 new genes associated with head and neck cancer 10252 21 Million Preemie Babies Die Each Year 3A Report 58826 11 Million Preemie Babies Die Each Year 3A Report 58826 21 Million Preemie Babies Die Each Year 3A Report 58826 3
... announced today the 28 recipients of the 2009 Seed Grant Research Program. ... physician residents and fellows to conduct basic science, applied or clinical research ... four categories: , , , ... HIV/AIDS , Leukemia , ...
... 6 B-R-A-H-M-S,Aktiengesellschaft today announced it has submitted ... (FDA) to market its patented B-R-A-H-M-S,MR-proANP Kryptor Test. ... (ANP) is predominantly produced in the atrium,of the ... in the,circulation. ANP is involved in natriuresis, diuresis, ...
Other Medicine Technology:AMA Foundation Announces Seed Grant Research Recipients 2AMA Foundation Announces Seed Grant Research Recipients 3FDA Submission of B-R-A-H-M-S MR-proANP Kryptor 2
(Date:2/9/2010)... Center have found a direct link between neighborhood ... in African American women. The study, which appears ... , is the first prospective study to examine ... of type 2 diabetes in a large, geographically ... diabetes is estimated to affect 20.6 million people ...
(Date:2/9/2010)... Texas , Feb. 9 ... and project coordinator for the University of North ... Health Science Center , was instrumental in recently identifying ... in the Patio 29 cemetery. ,, The Chilean ... lead geneticist for a process audit team of the ...
(Date:2/9/2010)... most comprehensive study to date of secondhand smoke exposure ... journal Addiction . The study, carried out by ... reveals that exposure to household secondhand smoke among children ... researchers wanted to find out if there were ways ... children in private households, and whether those levels were ...
(Date:2/9/2010)... more effective in persuading young women to use birth ... according to a new study. , Researchers found that ... teen pregnancy felt more vulnerable two weeks after watching ... using birth control. , However, those who watched a ... were unmoved, and had no change in their intentions ...
(Date:2/9/2010)... 2010) AcademyHealth today recognized research that improves patient ... Services Research (HSR) Impact Award. The WHO Surgical ... ensure adherence to basic safety standards of care. ... that clearly translated into policy and, ultimately, made ... W. David Helms, Ph.D. "The WHO Surgical Safety ...
Breaking Medicine News(10 mins):Health News:Neighborhood socioeconomic status and diabetes 2Health News:UNT Health Science Center's Roby Helps Identify Bodies of Chile's Patio 29 2Health News:UNT Health Science Center's Roby Helps Identify Bodies of Chile's Patio 29 3Health News:Exposure to secondhand smoke among children in England has declined since 1996 2Health News:TV drama can be more persuasive than news program, study finds 2Health News:TV drama can be more persuasive than news program, study finds 3Health News:TV drama can be more persuasive than news program, study finds 4Health News:2010 HSR Impact Award recognizes surgical safety research 2
... Island College Hospital in Brooklyn is in news for the ... Long Island College Hospital are investigating the circumstances that led ... the wrong side of a patient’s brain to remove a ... as stable after a corrective surgery was conducted on the ...
... After waging wars over many drug formulations the pharma majors ... set in motion by the dramatic announcement of Indian firm ... less than a U.S. dollar a day. Not to be ... own production of anti retroviral drugs for AIDS treatment. , ...
... 7 months was the first recipient of a bloodless ... America. The seven month old, Aiden Michael Rush, whose ... to receive transfusions. The boy received 20% of his ... the children’s hospital in Los Angeles. , To avoid ...
... overcome a major obstacle to treating brain ailments such ... studies in rats, researchers from the Stroke Lab and ... “a direct path from the nose to the brain” ... from foreign substances, including drugs. Senior investigator Dr. ...
... The gay capital? of the world, San Francisco is now reeling ... In the past one-year the rate of infection has actually doubled ... men, who are also intra venous drug users, the rates are ... ,Hold your breath! The successful control of spread of HIV ...
... is a gift, exclusive to the blessed. The less ... problems such as early morning headaches or serious daytime ... its mild or moderate form is commonly experienced. Sleep ... breathing during sleep. Most individuals may have less severe ...
Other Medicine News:Health News:Nasal Spray Could Take Drugs Direct to Brain. 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: